Detalles de la búsqueda
1.
A review and metanalysis of metronomic oral single-agent cyclophosphamide for treating advanced ovarian carcinoma in the era of precision medicine.
J Oncol Pharm Pract
; 30(1): 173-181, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38018146
2.
Correlation between sentinel lymph node biopsy and non-sentinel lymph node metastasis in patients with cN0 breast carcinoma: comparison of invasive ductal carcinoma and invasive lobular carcinoma.
World J Surg Oncol
; 22(1): 100, 2024 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38627759
3.
A retrospective, real-life analysis of metronomic oral single-agent cyclophosphamide for the treatment of platinum-pretreated advanced ovarian carcinoma in Italy.
J Oncol Pharm Pract
; : 10781552231189867, 2023 Jul 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37501558
4.
Breast Cancer in Two Ex-Votos, A Millennia Apart: Patients' Hope and Faith Expressed Through the Centuries in Votive Offerings.
J Relig Health
; 62(3): 1976-1984, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36853408
5.
Fulvestrant and trastuzumab in patients with luminal HER2-positive advanced breast cancer (ABC): an Italian real-world experience (HERMIONE 9).
Breast Cancer Res Treat
; 190(1): 103-109, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34453206
6.
Second-line Eribulin in Triple Negative Metastatic Breast Cancer patients. Multicentre Retrospective Study: The TETRIS Trial.
Int J Med Sci
; 18(10): 2245-2250, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33859534
7.
NEPA as antiemetic prophylaxis after failure of 5HT3-RA plus dexamethasone in patients receiving carboplatin and gemcitabine chemotherapy: A monocentric real-life experience.
J Oncol Pharm Pract
; 27(3): 609-613, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32507099
8.
Effects of the number of removed lymph nodes on survival outcome in patients with sentinel node-negative breast cancer.
World J Surg Oncol
; 19(1): 306, 2021 Oct 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34666764
9.
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence.
J Cell Physiol
; 235(11): 7900-7910, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31943171
10.
Does Smoking Cessation at Primary Diagnosis Reduce the Recurrence Risk of Nonmuscle-Invasive Bladder Cancer? Results of a Prospective Study.
Urol Int
; 104(5-6): 396-401, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32369816
11.
Abemaciclib pharmacology and interactions in the treatment of HR+/HER2- breast cancer: a critical review.
Ther Adv Drug Saf
; 15: 20420986231224214, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38665218
12.
The Impact of Neoadjuvant Chemotherapy on Axillary Surgical Management of Patients With Breast Cancer and Positive Axillary Lymph Nodes.
Anticancer Res
; 44(5): 2047-2053, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38677748
13.
The Consistency and Quality of ChatGPT Responses Compared to Clinical Guidelines for Ovarian Cancer: A Delphi Approach.
Curr Oncol
; 31(5): 2796-2804, 2024 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38785493
14.
Abemaciclib-associated Diarrhea: An Exploratory Analysis of Real-life Data.
Anticancer Res
; 43(3): 1291-1299, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36854501
15.
Outcomes of Sentinel Lymph Node Biopsy for Patients With Node-positive Breast Cancer Treated With Neoadjuvant Chemotherapy.
Anticancer Res
; 43(10): 4643-4649, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37772556
16.
Stereotactic Radiotherapy in Early-Stage Breast Cancer in Neoadjuvant and Exclusive Settings: A Systematic Review.
Oncol Res Treat
; 46(3): 116-123, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36509043
17.
A Prospective Observational Study on the Structuring Process and Implementation of a Large Regional, Inter-hospital, Virtual Multidisciplinary Tumor Board on Prostate Cancer.
Anticancer Res
; 43(1): 501-508, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36585190
18.
Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer.
NPJ Breast Cancer
; 9(1): 73, 2023 Sep 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37684252
19.
Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1-3 node-positive rapidly proliferating breast cancer.
Breast Cancer Res Treat
; 125(3): 775-84, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21132360
20.
Metastatic seeding of colon adenocarcinoma manifesting as synchronous breast and chest wall localization: report of a case.
Surg Today
; 41(2): 242-6, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21264761